DK183582A - Fremgangsmaade til fremstilling af oxazolderivater - Google Patents

Fremgangsmaade til fremstilling af oxazolderivater Download PDF

Info

Publication number
DK183582A
DK183582A DK183582A DK183582A DK183582A DK 183582 A DK183582 A DK 183582A DK 183582 A DK183582 A DK 183582A DK 183582 A DK183582 A DK 183582A DK 183582 A DK183582 A DK 183582A
Authority
DK
Denmark
Prior art keywords
preparation
oxazold
derivatives
procedure
oxaprozin
Prior art date
Application number
DK183582A
Other languages
English (en)
Other versions
DK150604B (da
DK150604C (da
Inventor
A S Mughal
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of DK183582A publication Critical patent/DK183582A/da
Publication of DK150604B publication Critical patent/DK150604B/da
Application granted granted Critical
Publication of DK150604C publication Critical patent/DK150604C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK183582A 1981-04-28 1982-04-23 Analogifremgangsmaade til fremstilling af calciumoxaprozin DK150604C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8113074 1981-04-28
GB8113074 1981-04-28

Publications (3)

Publication Number Publication Date
DK183582A true DK183582A (da) 1982-10-29
DK150604B DK150604B (da) 1987-04-13
DK150604C DK150604C (da) 1987-12-07

Family

ID=10521427

Family Applications (1)

Application Number Title Priority Date Filing Date
DK183582A DK150604C (da) 1981-04-28 1982-04-23 Analogifremgangsmaade til fremstilling af calciumoxaprozin

Country Status (24)

Country Link
US (2) US4465838A (da)
EP (1) EP0063884B1 (da)
JP (1) JPS57181072A (da)
KR (1) KR880000871B1 (da)
AT (1) ATE14015T1 (da)
AU (1) AU544975B2 (da)
CA (1) CA1169867A (da)
CS (1) CS236674B2 (da)
DD (1) DD202017A5 (da)
DE (1) DE3264400D1 (da)
DK (1) DK150604C (da)
ES (1) ES8307230A1 (da)
FI (1) FI71314C (da)
GR (1) GR75913B (da)
HU (1) HU185276B (da)
IE (1) IE52909B1 (da)
IL (1) IL65443A (da)
MY (1) MY8700599A (da)
NZ (1) NZ200247A (da)
PH (1) PH18053A (da)
PL (1) PL136322B1 (da)
PT (1) PT74794B (da)
ZA (1) ZA822355B (da)
ZW (1) ZW7482A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US6726928B2 (en) * 1994-10-28 2004-04-27 R.P. Scherer Technologies, Inc. Process for preparing solid dosage forms for unpalatable pharmaceuticals
PL330145A1 (en) * 1996-05-20 1999-04-26 Searle & Co Pharmaceutic preparations containing sodium and potassum oxaprosin salt as well as that formed from tris
US7358254B2 (en) * 2001-07-13 2008-04-15 Bristol-Myers Squibb Company Method for treating atherosclerosis employing an aP2 inhibitor and combination
AU2006228869A1 (en) * 2005-03-30 2006-10-05 Astion Pharma A/S Oxaprozin or a closely related compound for the treatment of eczema
US20060222671A1 (en) * 2005-03-30 2006-10-05 Astion Development A/S Dermatological compositions and salts for the treatment of dermatological diseases
PL2340296T3 (pl) * 2008-08-26 2015-03-31 Dorf Ketal Chemicals I Private Ltd Nowy dodatek do hamowania korozji kwasowej i sposób stosowania nowego dodatku
KR20140065862A (ko) * 2012-11-22 2014-05-30 에스케이케미칼주식회사 발포성 속붕해성 이매티닙 제제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206403A (en) * 1966-12-15 1970-09-23 Wyeth John & Brother Ltd Oxazoles
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles

Also Published As

Publication number Publication date
FI821324L (fi) 1982-10-29
US4532253A (en) 1985-07-30
JPS57181072A (en) 1982-11-08
JPH0261466B2 (da) 1990-12-20
ZW7482A1 (en) 1983-11-09
PT74794A (en) 1982-05-01
FI821324A0 (fi) 1982-04-15
IL65443A (en) 1985-04-30
GR75913B (da) 1984-08-02
DD202017A5 (de) 1983-08-24
DK150604B (da) 1987-04-13
DE3264400D1 (en) 1985-08-01
PL236145A1 (da) 1982-12-06
EP0063884B1 (en) 1985-06-26
AU544975B2 (en) 1985-06-27
KR830009772A (ko) 1983-12-23
HU185276B (en) 1984-12-28
ATE14015T1 (de) 1985-07-15
PL136322B1 (en) 1986-02-28
IE52909B1 (en) 1988-04-13
EP0063884A1 (en) 1982-11-03
ZA822355B (en) 1983-11-30
ES511730A0 (es) 1983-07-01
MY8700599A (en) 1987-12-31
PT74794B (en) 1983-11-07
CA1169867A (en) 1984-06-26
US4465838A (en) 1984-08-14
IL65443A0 (en) 1982-07-30
FI71314C (fi) 1986-12-19
FI71314B (fi) 1986-09-09
PH18053A (en) 1985-03-18
ES8307230A1 (es) 1983-07-01
DK150604C (da) 1987-12-07
KR880000871B1 (ko) 1988-05-28
IE820766L (en) 1982-10-28
NZ200247A (en) 1984-10-19
CS236674B2 (en) 1985-05-15
AU8237882A (en) 1982-11-04

Similar Documents

Publication Publication Date Title
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
MX9200180A (es) DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE.
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO158419C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-diaminocyklobuten-3,4-dioner.
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
DK267979A (da) Fremgangsmaade til fremstilling af aryloxypropanolaminer
ES515375A0 (es) Procedimiento para la preparacion de derivados de 3-piridilo y 2-piracinilo.
NO158417C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer.
DK183582A (da) Fremgangsmaade til fremstilling af oxazolderivater
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
DK635988D0 (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
NO891574L (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO158299C (no) Analogifremgangsmaate for fremstilling av 17, 18-dehydro-apovincaminol-l-3', 4', 5'-trimethoxy-benzoat.
NO160136C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av benzoylfenylpiperidin.
NO160436C (no) Analogifremgangsmaate til fremstilling av farmasoeytisk anvendbare substituerte benzofenoner.
NO813577L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperdin-derivater.
ES509028A0 (es) Procedimiento para la preparacion de derivados espiro-1 farmaceuticamente activos.
IT8520877A0 (it) Procedimento di preparazione di derivati del 9h-xanthen-9-one, derivati cosi' ottenuti e loro impiego terapeutico.
NO160443C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO160519C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive s- adenosylmethioninacylderivater.
NO882000D0 (no) Fremgangsmaate til fremstilling av ren dimetyleter.
NO902396L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.

Legal Events

Date Code Title Description
PUP Patent expired